MedPath
NMPA Approval

Dalteparin Sodium Injection

国药准字H20213489

June 16, 2021

Drug Information

达肝素钠注射液

注射剂

0.2ml:5000IU

化学药品

June 16, 2021

Company Information

Applicant Company

江苏省常州市武进经济开发区果香路18号

Manufacturing Company

江苏省常州市武进经济开发区果香路18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达肝素钠注射液 - NMPA 批准文号 | MedPath